| Management target | Revenue 10.0% FY27 |
|---|
| Revenue growth | 9.48% YoY in Q1 FY27. |
|---|---|
| Margins | Higher raw/packing material costs; price hikes taken to offset. |
| Demand visibility | Strong in Women's Hygiene; soft in Pain Management rubs. |
| Management confidence | High for double-digit annual growth. |
Growth
Net Sales grew to 102.97 Cr from 94.05 Cr. PAT fell to 4.37 Cr from 8.31 Cr due to exceptional items.
Outlook
Targeting double-digit revenue and profit growth for FY27. Projecting 15 Cr from razors and 10 Cr from Plastry.
Risks
Pain management volume de-growth (-3.4%), West Asia war impacting COGS, and new FSSAI restrictions on electrolyte drinks.
Investor Presentation filed with NSE, NSE: AMRUTANJAN. Summary written with AI assistance from the document.
Amrutanjan Health Care Ltd: key numbers
- Share price
- ₹506.35
- Market cap
- ₹1,464 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 27.1×Sector 50.4×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 2.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amrutanjan Health Care Ltd
All →Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.
Amrutanjan Health Care Q1 FY27 Results: Net Profit ₹4.4 Cr, Down 47.0% YoY
Amrutanjan Health Care Ltd reported revenue from operations of ₹103 Cr (+9.6% YoY) and net profit of ₹4.4 Cr (-47.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹4.4 Cr · -47.0% YoY
Amrutanjan Health Care Earnings Call: Key Takeaways
Amrutanjan reported 11.23% revenue growth for FY26 with significant 37.2% jump in Q4 profit before exceptional items. Strategy focuses on power brands, distribution expansion, and digitization.
Amrutanjan Health Care Earnings Call: Key Takeaways
Amrutanjan reported FY26 net sales of ₹502.55 Cr (up 11.23%) and PAT of ₹57.92 Cr (up 13.95%). Strategy focuses on expanding Pain Management, Women's Hygiene, and new Personal Care categories.
Amrutanjan Health Care Q4 FY26 Results: Net Profit ₹16.2 Cr, Up 6.6% YoY
Amrutanjan Health Care Ltd reported revenue from operations of ₹149.8 Cr (+10.6% YoY) and net profit of ₹16.2 Cr (+6.6% YoY) for Q4 FY26.
- Key figure
- Net profit ₹16.2 Cr · +6.6% YoY